DENTSPLY SIRONA (NASDAQ:XRAY) Stock Breaks Below 50-Day Moving Average - Here's What Happened

Key Points

• DENTSPLY SIRONA shares fell below their 50-day moving average, trading as low as $9.23 and last changing hands at $9.24, versus a 50-day average of $9.48.
• The company missed quarterly expectations, reporting EPS of $0.29 versus $0.31 forecast and revenue of $836 million versus $861.68 million expected; revenue declined 7.5% year over year.
• Analyst sentiment is cautious: MarketBeat lists an average “Reduce” rating and a $12.42 average price target, while several firms recently cut their targets or ratings.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s share price crossed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $9.48 and traded as low as $9.23. DENTSPLY SIRONA shares last traded at $9.24, with a volume of 5,492,190 shares traded.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on XRAY. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Leerink Partners cut their price objective on DENTSPLY SIRONA from $14.00 to $10.00 and set a "market perform" rating for the company in a research report on Wednesday, October 14th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an "outperform" rating on the stock in a report on Monday, October 26th. Zacks Research cut shares of DENTSPLY SIRONA from a "hold" rating to a "strong sell" rating in a research report on Monday. Finally, Mizuho lowered their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating for the company in a research note on Thursday, October 22nd. Three analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Reduce" and an average target price of $12.42.

DENTSPLY SIRONA Price Performance

The stock's fifty day moving average price is $9.48 and its two-hundred day moving average price is $11.22. The firm has a market capitalization of $1.83 billion, a price-to-earnings ratio of -14.90, a price-to-earnings-growth ratio of 1.43 and a beta of 0.87. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The business had revenue of $836.00 million during the quarter, compared to analyst estimates of $861.68 million. During the same period last year, the company earned $0.37 earnings per share. The business's revenue for the quarter was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently modified their holdings of the company. AlphaCore Capital LLC raised its position in shares of DENTSPLY SIRONA by 9.9% in the third quarter. AlphaCore Capital LLC now owns 14,386 shares of the medical instruments supplier's stock valued at $127,000 after buying an additional 1,298 shares during the last quarter. Bfsg LLC grew its stake in DENTSPLY SIRONA by 13.4% in the 3rd quarter. Bfsg LLC now owns 22,230 shares of the medical instruments supplier's stock worth $197,000 after acquiring an additional 2,620 shares during the period. Brighton Jones LLC grew its stake in DENTSPLY SIRONA by 7.6% in the 3rd quarter. Brighton Jones LLC now owns 37,673 shares of the medical instruments supplier's stock worth $334,000 after acquiring an additional 2,668 shares during the period. Allworth Financial LP raised its holdings in DENTSPLY SIRONA by 163.8% in the 2nd quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier's stock valued at $51,000 after acquiring an additional 2,990 shares during the last quarter. Finally, Focus Advisor Solutions LLC raised its holdings in DENTSPLY SIRONA by 15.1% in the 3rd quarter. Focus Advisor Solutions LLC now owns 27,233 shares of the medical instruments supplier's stock valued at $241,000 after acquiring an additional 3,568 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.